Skip to content

Clinical trials

Phase 3 Urologic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urologic Diseases Phase: Phase 3 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20102
20111
20121
20131
20182
20193
20201
20211
20231
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting4
Terminated4
Recruiting3
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Astellas Pharma Europe Ltd.2
Astellas Pharma Inc2
Cook MyoSite2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Medical Enterprises Europe B.V.2
Urovant Sciences GmbH2
APOGEPHA Arzneimittel GmbH1
Astellas Pharma Global Development, Inc.1
Biohaven Therapeutics Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urologic Diseases25
Kidney Diseases7
Urinary Bladder Diseases7
Renal Insufficiency, Chronic6
Glomerulonephritis5
Glomerulonephritis, IGA5
Neoplasms5
Neoplasms by Site5
Urinary Bladder Neoplasms5
Urinary Bladder, Overactive5

Trials

Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.